vs

Side-by-side financial comparison of BIOLIFE SOLUTIONS INC (BLFS) and Epsilon Energy Ltd. (EPSN). Click either name above to swap in a different company.

BIOLIFE SOLUTIONS INC is the larger business by last-quarter revenue ($18.8M vs $14.8M, roughly 1.3× Epsilon Energy Ltd.). BIOLIFE SOLUTIONS INC runs the higher net margin — 58.9% vs -83.9%, a 142.9% gap on every dollar of revenue. On growth, Epsilon Energy Ltd. posted the faster year-over-year revenue change (65.7% vs 24.3%). Over the past eight quarters, Epsilon Energy Ltd.'s revenue compounded faster (36.2% CAGR vs 1.0%).

Biolife Solutions Inc. develops, manufactures and distributes specialized biopreservation products and cold chain management solutions for the cell and gene therapy, biopharmaceutical and regenerative medicine industries. It offers cryopreservation media, automated thawing systems, and temperature monitoring tools, serving biotech firms, research institutions and clinical labs globally.

Epsilon Composite is a French company created in 1987 by Stephane LULL, its current CEO. The company was founded in January 1987. Its production site is located in Gaillan, France. Stéphane Lull is the CEO.

BLFS vs EPSN — Head-to-Head

Bigger by revenue
BLFS
BLFS
1.3× larger
BLFS
$18.8M
$14.8M
EPSN
Growing faster (revenue YoY)
EPSN
EPSN
+41.4% gap
EPSN
65.7%
24.3%
BLFS
Higher net margin
BLFS
BLFS
142.9% more per $
BLFS
58.9%
-83.9%
EPSN
Faster 2-yr revenue CAGR
EPSN
EPSN
Annualised
EPSN
36.2%
1.0%
BLFS

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
BLFS
BLFS
EPSN
EPSN
Revenue
$18.8M
$14.8M
Net Profit
$11.1M
$-12.4M
Gross Margin
Operating Margin
7.2%
-129.0%
Net Margin
58.9%
-83.9%
Revenue YoY
24.3%
65.7%
Net Profit YoY
-11.1%
-1535.0%
EPS (diluted)
$0.23
$-0.55

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BLFS
BLFS
EPSN
EPSN
Q4 25
$18.8M
$14.8M
Q3 25
$28.1M
$9.0M
Q2 25
$25.4M
$11.6M
Q1 25
$23.9M
$16.2M
Q4 24
$15.1M
$8.9M
Q3 24
$21.4M
$7.3M
Q2 24
$19.7M
$7.3M
Q1 24
$18.4M
$8.0M
Net Profit
BLFS
BLFS
EPSN
EPSN
Q4 25
$11.1M
$-12.4M
Q3 25
$621.0K
$1.1M
Q2 25
$-15.8M
$1.6M
Q1 25
$-448.0K
$4.0M
Q4 24
$12.5M
$-760.8K
Q3 24
$-1.7M
$366.0K
Q2 24
$-20.7M
$815.7K
Q1 24
$-10.2M
$1.5M
Operating Margin
BLFS
BLFS
EPSN
EPSN
Q4 25
7.2%
-129.0%
Q3 25
-0.3%
6.7%
Q2 25
-65.5%
7.1%
Q1 25
-5.1%
44.3%
Q4 24
3.6%
6.8%
Q3 24
-2.0%
3.3%
Q2 24
-6.6%
16.0%
Q1 24
-17.9%
17.6%
Net Margin
BLFS
BLFS
EPSN
EPSN
Q4 25
58.9%
-83.9%
Q3 25
2.2%
11.9%
Q2 25
-62.3%
13.3%
Q1 25
-1.9%
24.8%
Q4 24
82.5%
-8.5%
Q3 24
-8.0%
5.0%
Q2 24
-105.1%
11.2%
Q1 24
-55.4%
18.9%
EPS (diluted)
BLFS
BLFS
EPSN
EPSN
Q4 25
$0.23
$-0.55
Q3 25
$0.01
$0.05
Q2 25
$-0.33
$0.07
Q1 25
$-0.01
$0.18
Q4 24
$0.27
$-0.04
Q3 24
$-0.04
$0.02
Q2 24
$-0.45
$0.04
Q1 24
$-0.22
$0.07

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BLFS
BLFS
EPSN
EPSN
Cash + ST InvestmentsLiquidity on hand
$33.0M
$9.0M
Total DebtLower is stronger
$5.0M
Stockholders' EquityBook value
$371.9M
$124.7M
Total Assets
$405.9M
$228.2M
Debt / EquityLower = less leverage
0.01×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BLFS
BLFS
EPSN
EPSN
Q4 25
$33.0M
$9.0M
Q3 25
$29.5M
$12.8M
Q2 25
$31.9M
$9.9M
Q1 25
$66.9M
$6.9M
Q4 24
$91.5M
$6.5M
Q3 24
$24.0M
$8.3M
Q2 24
$22.0M
$8.6M
Q1 24
$29.7M
$2.3M
Total Debt
BLFS
BLFS
EPSN
EPSN
Q4 25
$5.0M
Q3 25
$7.5M
Q2 25
$10.1M
Q1 25
$12.9M
Q4 24
$15.9M
Q3 24
$20.1M
Q2 24
$21.1M
Q1 24
$24.3M
Stockholders' Equity
BLFS
BLFS
EPSN
EPSN
Q4 25
$371.9M
$124.7M
Q3 25
$353.7M
$100.2M
Q2 25
$347.2M
$100.2M
Q1 25
$352.6M
$99.7M
Q4 24
$348.9M
$96.7M
Q3 24
$325.5M
$98.4M
Q2 24
$321.4M
$99.6M
Q1 24
$333.4M
$99.9M
Total Assets
BLFS
BLFS
EPSN
EPSN
Q4 25
$405.9M
$228.2M
Q3 25
$392.1M
$126.3M
Q2 25
$387.2M
$123.6M
Q1 25
$395.1M
$125.5M
Q4 24
$399.5M
$120.5M
Q3 24
$381.7M
$121.8M
Q2 24
$375.0M
$121.1M
Q1 24
$401.6M
$125.1M
Debt / Equity
BLFS
BLFS
EPSN
EPSN
Q4 25
0.01×
Q3 25
0.02×
Q2 25
0.03×
Q1 25
0.04×
Q4 24
0.05×
Q3 24
0.06×
Q2 24
0.07×
Q1 24
0.07×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BLFS
BLFS
EPSN
EPSN
Operating Cash FlowLast quarter
$4.9M
$-277.0K
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
0.44×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BLFS
BLFS
EPSN
EPSN
Q4 25
$4.9M
$-277.0K
Q3 25
$6.1M
$4.0M
Q2 25
$7.4M
$8.3M
Q1 25
$1.7M
$8.6M
Q4 24
$1.6M
$5.0M
Q3 24
$4.8M
$2.7M
Q2 24
$6.5M
$5.4M
Q1 24
$-4.5M
$3.7M
Cash Conversion
BLFS
BLFS
EPSN
EPSN
Q4 25
0.44×
Q3 25
9.83×
3.70×
Q2 25
5.38×
Q1 25
2.14×
Q4 24
0.13×
Q3 24
7.50×
Q2 24
6.60×
Q1 24
2.45×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BLFS
BLFS

Segment breakdown not available.

EPSN
EPSN

Gas Oil Ngls And Condensate$13.3M90%
Gas Gathering And Compression$1.5M10%

Related Comparisons